KRAS and neoplasm: Overall, in 26 cases ctDNA analysis revealed a KRAS mutation that was not previously found in tumour tissue (i.e., 22 patients previously classified as having KRAS wild-type tumours and 4 patients with KRAS mutant tumours who were found to have a different KRAS mutation in ctDNA).